NYSE:WCC
NYSE:WCCTrade Distributors

WESCO International (WCC): Evaluating Valuation After Upbeat Q3 Results and Upgraded Sales Outlook

WESCO International (WCC) jumped into focus after outperforming in the third quarter of 2025 and raising its full-year sales outlook, highlighting momentum in segments such as data centers and electrification. See our latest analysis for WESCO International. WESCO International’s strong third-quarter results and upgraded growth outlook have reignited investor enthusiasm, reflected in a 25.4% one-month share price return and a 50% gain year-to-date. With a 30.3% total shareholder return over...
NYSE:CTVA
NYSE:CTVAChemicals

Will Stronger 2025 Outlook and Bioinsecticide Launch Shift Corteva’s (CTVA) Growth Narrative?

Corteva, Inc. recently raised its full-year 2025 earnings guidance, reported third quarter sales of US$2.62 billion, and posted reduced net losses, reinforcing positive business momentum for the company. The company also introduced new crop protection solutions, including its first bioinsecticide Goltrevo™, and continued its share repurchase program, highlighting advancements in sustainable agriculture and ongoing capital management efforts. We'll explore how Corteva's stronger earnings...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

APA (APA): Assessing Valuation After Profit Rebound and Upgraded U.S. Oil Production Guidance

APA (APA) caught extra attention after its latest quarterly earnings, as the company bounced back into profitability from last year’s loss. Investors are also watching because APA raised its U.S. oil production guidance for the coming quarter. See our latest analysis for APA. APA’s stock has caught a fresh wave of momentum lately, with a 10.3% 7-day share price return and an impressive 16.6% gain over the past 90 days, as investors responded positively to stronger earnings and updated...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Are New Partnerships Enough to Justify Netflix’s 39% Rally in 2025?

Wondering if Netflix is as good a value as its popularity and streaming dominance suggest? You are not alone, and digging into the numbers now might surprise you. Netflix’s stock has delivered an impressive 30.5% jump so far this year, even after a recent 5.0% dip over the past month, and has climbed a remarkable 39.4% in the last year. Shares have been buzzing since Netflix announced new international partnerships and secured exclusive content deals, fueling speculation...
NYSE:IT
NYSE:ITIT

Does Gartner’s (IT) AI Commentary Signal a Shift in Long-Term Growth and Industry Positioning?

Earlier this month, Gartner announced a shelf registration enabling the potential issuance of various securities and reported third-quarter results, including US$1.52 billion revenue, US$35.36 million net income, and notable non-cash impairments. Gartner’s updated guidance projects consolidated 2025 revenue of at least US$6.48 billion, reflecting growth in its Insights and Conferences segments amidst rising interest in the impact of AI on IT and enterprise risk. We'll examine how Gartner's...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Arm Holdings (ARM) Is Down 7.1% After Announcing AI Chip Plans and Q2 Earnings – Has The Bull Case Changed?

Arm Holdings recently reported its second quarter 2025 earnings, posting US$1.14 billion in sales and US$238 million in net income, with basic earnings per share rising to US$0.22. The company also revealed plans to develop its own first-party AI accelerator chips for data centers, signaling a significant expansion beyond its traditional licensing model. We'll examine how Arm Holdings' entry into first-party AI chip production could reshape its future growth outlook. Outshine the giants:...
NYSE:TNC
NYSE:TNCMachinery

How Investors May Respond To Tennant (TNC) Reaffirming 2025 Outlook Despite Declining Earnings and Sales

In its most recent update, Tennant Company reported third quarter 2025 results with US$303.3 million in sales and US$14.9 million net income, both down from the prior year, and reaffirmed its 2025 earnings guidance while providing share repurchase updates. An interesting takeaway is that while earnings and sales declined, Tennant maintained its full-year outlook, signaling management's continued confidence in its operational trajectory despite recent headwinds. We'll explore how Tennant's...
NYSE:CCI
NYSE:CCISpecialized REITs

The Bull Case For Crown Castle (CCI) Could Change Following Utility-Focused Anterix TowerX Partnership Announcement

On November 12, 2025, Anterix and Crown Castle jointly announced the launch of Anterix TowerX, a turnkey service designed to accelerate and optimize the deployment of 900 MHz private LTE networks for utilities across the U.S., leveraging Crown Castle’s network of more than 40,000 tower sites. This collaboration not only streamlines wireless infrastructure projects for the utility sector but also highlights Crown Castle’s deeper integration into nationwide critical infrastructure...
NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

Why Is Navitas (NVTS) Raising $100 Million to Shift Focus Toward AI and Industrial Power Markets?

Navitas Semiconductor recently closed a US$100 million private placement, issuing over 14.8 million new shares to accredited investors, with capital earmarked to fund expansion initiatives in high-power markets including AI data centers and industrial electrification. This move comes as Navitas pursues a business transition under newly appointed CEO Chris Allexandre, including a shift away from lower-margin consumer and mobile segments and the announcement of a high-profile partnership to...
NasdaqGS:NSIT
NasdaqGS:NSITElectronic

How the Launch of Insight AI Has Changed the Investment Story at Insight Enterprises (NSIT)

On November 12, 2025, Insight Enterprises announced the launch of Insight AI, a comprehensive suite of services designed to help organizations overcome common barriers to AI adoption using pragmatic roadmaps, expert tools, and delivery accelerators. This new offering integrates Insight's recent acquisitions and its own internal AI expertise to provide clients with clear value realization and reduced risk in enterprise AI initiatives. We will explore how Insight AI's promise of faster,...
NYSE:ES
NYSE:ESElectric Utilities

Did Eversource Energy's (ES) Strong Earnings Rebound Just Shift Its Long-Term Investment Narrative?

Eversource Energy recently reported third quarter and nine-month 2025 earnings, showing higher sales at US$3.22 billion and strong profitability, turning around from a net loss a year earlier. The company also reaffirmed its full-year and long-term earnings guidance, indicating confidence in the underlying strength of its core utility business and future earnings outlook. With quarterly net income rebounding sharply, we'll explore how this performance supports the company's investment...
NYSE:CVS
NYSE:CVSHealthcare

CVS Health (CVS): Evaluating Valuation After Rite Aid Prescription File Acquisition and Renewed Focus on Core Profits

CVS Health (CVS) stock is getting more attention as the company sharpens its focus on profitable areas and deepens its reach into pharmacy care. The acquisition of prescription files from Rite Aid and Bartell Drugs, along with improved financial results, is turning heads among investors. See our latest analysis for CVS Health. This year’s headline-grabbing moves from CVS Health, including the Rite Aid file acquisition and a focus on core profits, have clearly resonated with investors as...
NYSE:COTY
NYSE:COTYPersonal Products

Gucci License Dispute Could Be a Game Changer for Coty (COTY)

Earlier this month, Coty Inc. filed a lawsuit in the UK against Kering and Gucci over the planned transfer of the Gucci beauty and fragrance license to L'Oréal, with all parties confirming the current license will remain in effect until expiration in 2028. This legal dispute brings fresh uncertainty to Coty's operations and future licensed brand revenues, as it unfolds alongside recent earnings pressures and leadership changes. We'll explore how the pending Gucci license litigation could...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Lam Research (LRCX): Assessing Valuation After Analyst Upgrades and Bullish Earnings Forecasts

Lam Research (LRCX) recently saw its stock gain attention after analysts revised earnings estimates higher, resulting in a consensus rating between Strong Buy and Buy. This wave of renewed optimism has highlighted its near-term prospects for investors. See our latest analysis for Lam Research. Lam Research’s momentum has been building, with analyst optimism and solid earnings sentiment helping drive a 30-day share price return of 17.1% and an eye-catching 122.8% year-to-date gain. Even as...
NYSE:BKV
NYSE:BKVOil and Gas

A Look at BKV’s Valuation Following Strong Earnings and Expansion into Power and Carbon Capture

BKV (BKV) reported its third quarter results, showing a significant jump in both revenue and net income compared to last year. The company also shared plans to increase its stake in a power joint venture and move forward with carbon capture projects. See our latest analysis for BKV. BKV’s strong earnings growth and renewed push into power and carbon capture have drawn plenty of market buzz, with the share price jumping 27% over the last 30 days. Momentum appears to be building as investors...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Group (NMRK): Evaluating Valuation Following Strong Q3 Earnings and Upgraded 2025 Growth Outlook

Newmark Group (NMRK) just reported strong third-quarter results, with both revenue and net income climbing well above last year. The company also revised its 2025 revenue guidance upward and is projecting roughly 18% growth at the midpoint. See our latest analysis for Newmark Group. It’s been an eventful year for Newmark Group, with headline earnings growth followed by fresh appointments to its European Finance team and high-profile conference appearances that signal a company on the move...
NYSE:GXO
NYSE:GXOLogistics

GXO Logistics (GXO): Evaluating Valuation Following Q3 Earnings Growth and Guidance Reaffirmation

GXO Logistics (GXO) just posted its third-quarter results, revealing higher sales and net income compared to last year. The company also reconfirmed its full-year outlook for organic revenue growth. These latest moves are drawing fresh investor interest. See our latest analysis for GXO Logistics. Momentum has started to return for GXO Logistics as recent quarterly results and new leadership have boosted confidence, even after a tough period that saw rising costs and a valuation downgrade. The...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

A Look at CrowdStrike (CRWD) Valuation Following Strategic Partnership With F5

CrowdStrike Holdings (CRWD) shares are drawing attention after the company revealed a strategic partnership with F5 to integrate its Falcon Sensor and OverWatch Threat Hunting with F5’s BIG-IP platforms. This move extends CrowdStrike’s reach to the network edge. See our latest analysis for CrowdStrike Holdings. CrowdStrike’s string of partnerships and product launches, from expanded AI-driven integrations with CoreWeave to bringing Falcon capabilities to F5’s BIG-IP, has kept momentum firmly...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

Does LKQ's (LKQ) Share Buyback and Guidance Shift Reveal a New Chapter in Capital Allocation?

LKQ Corporation recently reported its third-quarter 2025 earnings, updated its full-year guidance, declared a US$0.30 dividend, and announced the upcoming departure of Director Jody G. Miller, while also completing a significant share buyback program totaling over US$2.9 billion. The company has sustained service and inventory levels despite declining repairable claims, emphasizing its ongoing multi-year operational transformation and maintaining investor focus on margin improvement and...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI): Evaluating Valuation Following Strong Earnings and New CTV Product Launches

Magnite (MGNI) saw its shares move after posting impressive quarterly results, with higher revenue and profit compared to last year. The company also introduced new product enhancements and strengthened partnerships across the connected TV and programmatic ad space. See our latest analysis for Magnite. Despite robust quarterly earnings and headline product partnerships, Magnite’s recent 30-day share price return of -18.8% and a sharp 90-day drop of nearly 40% highlight the volatility tech...
NYSE:WCN
NYSE:WCNCommercial Services

Is Waste Connections’ (WCN) Dividend Hike and New Acquisitions Redefining Its Long-Term Growth Approach?

In the past week, Waste Connections reported third quarter revenue that topped expectations, while adjusted earnings per share missed forecasts, and announced an 11.1% rise in its quarterly dividend alongside share buybacks equal to about 1% of its shares. The company also disclosed that year-to-date, it has completed or secured formal agreements on acquisitions totalling approximately US$300 million in annual revenue. Alongside updated financial results, Waste Connections is highlighting...
NasdaqGS:ZYME
NasdaqGS:ZYMEBiotechs

Zymeworks (ZYME) Is Up 7.3% After Reduced Net Loss and ADC Trial Launch - Has The Bull Case Changed?

Zymeworks Inc. recently reported a reduced net loss of US$19.6 million for the third quarter of 2025, began a Phase I trial for a new ADC candidate, and completed a substantial share buyback program, all alongside board changes. The company’s encouraging clinical progress, improved financials, and ongoing partnerships highlight renewed momentum in its oncology pipeline and capital management. We’ll explore how positive initial Phase I results for ZW191 contribute to shifting Zymeworks’...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Should CareTrust REIT’s (CTRE) Surging Q3 Results and Higher Earnings Forecast Prompt Investor Action?

Earlier this month, CareTrust REIT reported third quarter 2025 results, highlighting a very large increase in revenue and net income year-over-year, and updated its unaudited full-year 2025 earnings guidance to a range of US$1.41 to US$1.42 per diluted share. This performance underscores the effects of recent acquisitions and portfolio expansion, resulting in pronounced operational growth and higher expected earnings for the year. We will examine how these robust third quarter results and...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

CRISPR Therapeutics (CRSP): Assessing Valuation Following Promising Early CTX310 Cardiovascular Trial Results

CRISPR Therapeutics (NasdaqGM:CRSP) drew investor attention after unveiling early data from its Phase 1 CTX310 trial. The results revealed strong, lasting reductions in cardiovascular risk factors and a safety profile that supports ongoing development. See our latest analysis for CRISPR Therapeutics. Despite the buzz around CRISPR Therapeutics’ positive CTX310 trial results and solid progress in its gene-editing pipeline, the share price has pulled back sharply this month, down 23.6% in the...